Aesthetics & Personal Care Products
The Aesthetics and Personal Care Industry is a rapidly growing field that includes medical aesthetics, plastic surgery, cosmetics, pharmaceutical dermatology, cosmeceuticals, vitamins, nutraceuticals, and other areas. With advanced degrees in chemistry, biology, medicine and engineering, the professionals at Knobbe Martens expertly assist our clients in obtaining and protecting intellectual property in this field, both in the U.S. and internationally.
From obtaining valuable trademark rights for cosmetic brands to defending medical aesthetic companies in high stakes patent litigation, our team delivers a full range of intellectual property legal services. In addition to obtaining, enforcing and defending intellectual property rights, we have represented clients in negotiations with large cosmetic companies, helping forge alliances by licensing innovative technology and related intellectual property.
Leaders in aesthetics and personal care products routinely seek our strategic guidance before venturing into specific technology areas. Many consider us the “go-to” firm for intellectual property audits and due diligence, and regularly consult with our team prior to investing in specific technologies or launching products.
Our attorneys have experience in all areas of Aesthetics and Personal Care Products, including:
Vitamins & Supplements
Skin & Body Care
Alure Medical (Cosmetic Implants)
Amazing Shine Nails (Beauty Products)
AmorePacific Corporation (Cosmetics, Skin Care Products, Fragrances, Cleansers)
Anabolic Laboratories (Vitamins and Supplements)
Bai Brand (Nutritional Beverages)
Baseline Nutritionals (Vitamins and Supplements)
Beckham Brand Limited (Cologne, Hair and Skin Care Products, Cleansers)
Bee Line/Laila Ali (Cosmetics, Skin Care, Fragrances, Vitamins and Supplements)
Beauty Encounter (Beauty Products, Fragrances)
Birsect (Autologous Breast Implants)
Body Wise International (Vitamins and Supplements)
Bonnie Holmes Skincare (Skin Care Products)
Carol Cole Company (Facial Toning and Stimulation Devices)
Edge Systems Corporation (Microdermabrasion)
Evera Medical (Cosmetic Implants)
Faberge Services Limited (Cosmetics, Beauty Products and Fragrances)
Follea (Wigs and Hair Pieces)
h.wood.beauty (Cosmetics and Body Products)
Medicis Pharmaceutical Corporation (Pharmaceutical Dermatological Products)
Nobel Biocare (Dental Implants)
Nutrishop Corporation (Vitamins and Supplements)
Oshare (Skin Care, Moisturizers, Anti-aging Creams)
Phiten Co. (Cosmetics, Beauty and Skin Care Products, Cleansers)
PhotoMedex (Dermatology Devices, Laser Therapies)
Sultra Corporation (Hair and Skin Care Preparations)
Suzanne Somers (Cosmetics, Beauty Products, Nutritional and Dietary Supplements)
Temecula Cosmetic Company (dba Dè La Ron) (Cosmetics and Skin Care Products)
The FRS Company (Nutritional Beverages and Supplements)
Ulthera (Medical Aesthetics Using Ultrasound)
Urban Decay Cosmetics (Cosmetics, Beauty Products and Fragrances)
VisionQuest Online (Vitamins, Supplements, Skin Care Products)
Vitasport (Vitamins and Supplements)
VitaTech International (Vitamins and Supplements)
99¢ Only Stores (Beauty Products)
Medicis Pharmaceutical Corporation
Knobbe Martens has represented Medicis in patent prosecution as well as IP due diligence for several high profile deals since 2005, including acquiring the rights to market type A botulinum toxin, under the name DYSPORT®, which was approved by the FDA in 2009 for certain aesthetic uses, as well as acquiring the rights to a topical formulation of botulinum toxin presently under development.
Medicis is one of the leading independent specialty pharmaceutical companies in the United States focusing primarily on the treatment of dermatological and aesthetic conditions. Medicis is dedicated to helping patients attain a healthy and youthful appearance and self-image. Since 1988, Medicis has introduced more than 25 new products and formulations. Medicis products have earned wide acceptance by both physicians and patients due to their clinical effectiveness, high quality and cosmetic elegance. Medicis was the only pharmaceutical company in the world selected for the World's Most Ethical (WME) Companies list in 2011, a roster of high-performing organizations that have achieved leadership positions in their respective industries through exemplary business ethics and social responsibility.
Nobel is the world's leading manufacturer of dental implants, which are surgically implanted in the jaw to support prosthetic teeth and dental bridges. Knobbe Martens represents Nobel in patent litigation, arbitration, and prosecution matters.
A dentist sued Nobel Biocare alleging infringement of two patents relating to dental implant designs. The patents survived years of re-examination and reissue proceedings, and numerous other defendants settled. Nobel instead chose to have us challenge the patents, with $50 million in damages at stake. After obtaining key admissions from the dentist about the first patient on whom she used the patented implant, we obtained summary judgment of invalidity due to an on-sale bar. We also proved the second patent was invalid on multiple grounds, including the rare defense of “reissue recapture.” The dentist promptly dismissed the case.
We obtained summary judgment for Nobel Biocare. Competitor Sinlab accused Nobel of willfully infringing five U.S. patents for computerized dental surgery planning and customized dental prosthetics. The parties had litigated related patents for years in Canada and Europe. To quickly end this infringement threat, we filed a declaratory judgment action in the “rocket docket” of Eastern District of Virginia. Only six months after filing suit, the court granted summary judgment of non-infringement on all patents at issue. The case subsequently settled globally very favorably to Nobel.
The firm successfully defended Nobel Biocare, USA, Inc. in a binding arbitration proceeding involving a dental implant patent dispute where alleged past damages of $100 million and a possible injunction against future sales were at risk. Two of Nobel’s popular product lines were accused of infringement in this binding arbitration conducted by a panel of three patent attorneys. The patent had been previously enforced against over a dozen companies in the dental implant industry, resulting in settlements and payments of millions of dollars in royalties to the patent owner. Instead of owing any damages, Nobel Biocare was found not to infringe, and was awarded over $2 million in lawyers' fees and expenses.
The firm represented Ulthera Inc., developer of ultrasound technology to rejuvenate the skin, in IP diligence resulting in the successful completion of $10.5 million in Series C venture funding. The funding was led by New Enterprise Associates with participation by Apposite Capital LLP. The Ulthera® System, approved by the FDA for eyebrow lifting, combines traditional ultrasound imaging with focused ultrasound therapy to provide lifting and toning of the skin, including face and neck treatments and eyebrow lifts. Coverage of Ulthera on national television segments has raised awareness among millions of consumers, fueling demand for the treatment worldwide. Knobbe Martens has also helped to build and manage Ulthera’s patent and trademark portfolio.
Urban Decay Cosmetics
Knobbe Martens represents Urban Decay Cosmetics—recently acquired by L’Oreal—in trademark enforcement and litigation matters worldwide. For example, Knobbe recently represented Urban Decay in litigation against Victoria’s Secret regarding Urban Decay’s family of NAKED marks for cosmetics. The declaratory judgment action brought by Victoria’s Secret, Victoria’s Secret Stores Brand Management, Inc. v. Urban Decay Cosmetics, LLC, No. 2:12-cv-00693 (S.D. Ohio), was dismissed in light of a favorable settlement for Urban Decay.